3. Gestational diabetes mellitus (GDM)(diabetes diagnosed in the second or third trimester
of pregnancy that was not clearly overt diabetes prior to gestation) 4. Specific types of
diabetes due to other causes, eg, monogenic diabetes syndromes (such as neonatal
diabetes and maturity-onset diabetes of the young [MODY]), diseases of the exocrine
pancreas (such as cystic fibrosis), and drug-or chemical-induced diabetes (such as with
glucocorticoid use, in the treatment of HIV/AIDS, or after organ transplantation)

The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
ADA's current clinical practice recommendations and is intended to provide the components
of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of
care. Members of the ADA Professional Practice Committee, a multidisciplinary expert
committee, are responsible for updating the Standards of Care annually, or more frequently
as warranted. For a detailed description of ADA standards, statements, and reports, as well …

3. Gestational diabetes mellitus (GDM)(diabetes diagnosed in the second or third trimester
of pregnancy that is not clearly overt diabetes) 4. Specific types of diabetes due to other
causes, eg, monogenic diabetes syndromes (such as neonatal diabetes and maturity-onset
diabetes of the young [MODY]), diseases of the exocrine pancreas (such as cystic fibrosis),
and drug-or chemical-induced diabetes (such as in the treatment of HIV/AIDS or after organ
transplantation)

3. Gestational diabetes mellitus (GDM)(diabetes diagnosed in the second or third trimester
of pregnancy that is not clearly overt diabetes) 4. Specific types of diabetes due to other
causes, eg, monogenic diabetes syndromes (such as neonatal diabetes and maturity-onset
diabetes of the young [MODY]), diseases of the exocrine pancreas (such as cystic fibrosis),
and drug-or chemical-induced diabetes (such as with glucocorticoid use, in the treatment of
HIV/AIDS or after organ transplantation)